Tampa General Hospital has opened the TGH Cancer Institute Phase I Cancer Research Unit onsite at the academic health system’s main campus on Davis Islands in downtown Tampa.
Thyme Care has established Thyme Care Oncology Partners, a dedicated platform for oncology practices.
A research team led by Cancer Center at Illinois has received a $650,000 phase I grant from the National Science Foundation’s Convergence Accelerator.
Jasper Health, a virtual cancer care navigation and supportive care solution, is collaborating with The Leukemia & Lymphoma Society to provide comprehensive support and resources to blood cancer patients and their caregivers.
A phase I CAR T-cell therapy trial for the treatment of glioblastoma demonstrated promising clinical activity, according to research published in Nature Medicine.
Insights into the workings of PD-1 reveal how treatments that restrict its action can potentially be strengthened to improve their anticancer effect, a new study shows.
Cancer Center at Illinois member Jeff Chan, associate professor of chemistry, recently published research demonstrating the development of an activatable cancer therapeutic to help eliminate the side effects of traditional chemotherapies.
In a pilot study, a telephone-based dietary intervention designed to improve bowel function was shown to be widely acceptable to participants who had had surgery for rectal cancer.
In a policy statement, the American Society of Clinical Oncology calls for global equity in clinical trials.
The International Agency for Research on Cancer published a report titled “Maternal Orphans due to Cancer: The intergenerational impact of cancer deaths in women,” summarizing the findings from previous publications by researchers from IARC and partners that dealt with the theme of the intergenerational impact of cancer deaths in women.
